ZORYVE Trademark

Trademark Overview

On Wednesday, December 30, 2020, a trademark application was filed for ZORYVE with the United States Patent and Trademark Office. The USPTO has given the ZORYVE trademark a serial number of 90432545. The federal status of this trademark filing is REGISTERED as of Tuesday, November 8, 2022. This trademark is owned by Arcutis Biotherapeutics, Inc.. The ZORYVE trademark is filed in the Pharmaceutical Products category with the following description:

Dermatological pharmaceutical preparations; pharmaceutical preparations for the treatment of dermatological conditions, diseases and disorders
zoryve

General Information

Serial Number90432545
Word MarkZORYVE
Filing DateWednesday, December 30, 2020
Status700 - REGISTERED
Status DateTuesday, November 8, 2022
Registration Number6896192
Registration DateTuesday, November 8, 2022
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 3, 2021

Trademark Statements

Goods and ServicesDermatological pharmaceutical preparations; pharmaceutical preparations for the treatment of dermatological conditions, diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, March 25, 2021
Primary Code005
First Use Anywhere DateWednesday, August 10, 2022
First Use In Commerce DateWednesday, August 10, 2022

Trademark Owner History

Party NameArcutis Biotherapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressWestlake Village, CA 91361
Party NameArcutis Biotherapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWestlake Village, CA 91361
Party NameArcutis Biotherapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWestlake Village, CA 91361

Trademark Events

Event DateEvent Description
Saturday, January 2, 2021NEW APPLICATION ENTERED
Tuesday, January 12, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, January 12, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, January 12, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, March 25, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, June 30, 2021ASSIGNED TO EXAMINER
Wednesday, June 30, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 14, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 3, 2021PUBLISHED FOR OPPOSITION
Tuesday, August 3, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 28, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 30, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, November 30, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 30, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 21, 2022SOU TEAS EXTENSION RECEIVED
Monday, March 21, 2022SOU EXTENSION 1 FILED
Monday, March 21, 2022SOU EXTENSION 1 GRANTED
Thursday, September 15, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, March 23, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 15, 2022TEAS STATEMENT OF USE RECEIVED
Thursday, September 15, 2022USE AMENDMENT FILED
Thursday, September 15, 2022SOU EXTENSION 2 FILED
Thursday, September 29, 2022SOU EXTENSION 2 GRANTED
Thursday, September 29, 2022STATEMENT OF USE PROCESSING COMPLETE
Thursday, September 29, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, September 30, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 30, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, October 1, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, November 8, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, November 8, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED

Related Keywords

zoryve dermatological preparations pharmaceutical disorders diseases treatment conditions